Since 2013, Vishal Gulati is one of the most active stage agnostic digital health investors in Europe. His portfolio of over twenty companies spans a wide range of technology platforms including digital therapeutics, AI/ML, precision medicine, omics and synthetic biology (see portfolio here).  

Vishal invests directly as an angel investor or through syndicates or from the funds where he has a strategic relationship (Draper Esprit and Oxford Sciences Innovations).

Vishal serves on the boards of several private companies and his public appointments include committees of Cancer Research UK, the British Heart Foundation, Innovate UK/ MRC and Rueben College, University of Oxford.  

Previously, Vishal has worked at the Wellcome Trust and Atlas Venture. Prior to this, Vishal trained as a medical doctor and clinician scientist at Nuffield Department of Medicine in Oxford and Department of Medicine at Imperial College